Results were pre-released on July 14, so the confirmation is unlikely to move the stock significantly. The key tension is between volume growth (+2.5% admissions) and margin compression from payer mix deterioration. Watch the earnings call for commentary on exchange enrollment trends and the sustainability of Medicaid supplemental payments. The sharp drop in operating cash flow (-44%) and rising accounts receivable ($12.281B vs $10.867B at Dec 2025) warrant monitoring.
Price Chart
Executive Summary
HCA Healthcare reported Q2 2026 results consistent with its July 14 preview: revenue of $20.230B (+8.7% YoY) and GAAP EPS of $7.62 (+11.6% YoY), a 1.6% beat vs consensus of $7.50. However, the quarter was marked by a $400M unfavorable payer mix shift from health insurance exchange losses, partially offset by $400M in incremental Medicaid Supplemental Payment Program benefits. Full-year 2026 guidance was revised downward on net income and EPS, reflecting ongoing exchange-related headwinds. Operating cash flow fell sharply to $2.335B from $4.210B a year ago.
Key Financial Metrics
Key Facts
- Q2 2026 revenue $20.230B vs $18.605B YoY (+8.7%)
- GAAP diluted EPS $7.62 vs $6.83 YoY (+11.6%), beating consensus $7.50 by 1.6%
- Adjusted EBITDA $4.027B vs $3.849B YoY (+4.6%); margin contracted to 19.9% from 20.7%
- Payer mix shift from health insurance exchanges had ~$400M unfavorable impact on pre-tax income
- Incremental net benefit from Medicaid Supplemental Payment Programs of ~$400M in Q2
- Full-year 2026 guidance revised: net income $6.300-$6.700B (from $6.495-$7.035B), EPS $28.70-$30.50 (from $29.10-$31.50)
- Operating cash flow $2.335B in Q2 vs $4.210B in Q2 2025 (-44.5%)
- Repurchased 4.752M shares for $2.064B in Q2; $7.210B remaining under authorization
- Quarterly dividend declared at $0.78/share, payable Sept 30, 2026
- Same facility admissions +2.5%, same facility equivalent admissions +2.7%, ER visits +3.6%
Financial Impact
Q2 revenue beat consensus by ~$490M (2.5%); EPS beat by $0.12 (1.6%). Full-year net income guidance midpoint lowered by ~$265M (3.9%).
Risk Factors
- Expiration of enhanced premium tax credits at end of 2025 could worsen exchange-related payer mix headwinds in 2027
- Operating cash flow decline of 44% YoY raises questions about working capital management
- Guidance lowered on net income and EPS despite revenue range being narrowed upward
- Surgical volume declining (inpatient -2.3%, outpatient -3.4%) signals potential service mix shift away from higher-revenue procedures
- Total debt of $49.718B vs stockholders' deficit of $6.642B; leverage remains elevated
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-315151 |
| Document: hca-20260724.htm | 0001193125-26-315151 |
| Document: 0001193125-26-315151-index-headers.html | 0001193125-26-315151 |
| Document: 0001193125-26-315151-index.html | 0001193125-26-315151 |
| Document: 0001193125-26-315151.txt | 0001193125-26-315151 |
| 8-K Data (Synthetic) | 0001193125-26-315151 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 24, 2026 10w ago | 8-K | $382.19 $429.19 | ▲ +12.30% | ▲ +8.67% | $426.69 (+11.64%) |
Jul 14, 2026 11w ago | 8-K | $363.60 $411.44 | ▼ −13.16% | ▼ −10.67% | $426.69 (−17.35%) |
Jun 18, 2026 15w ago | 8-K | $375.17 $385.74 | ▲ +2.82% | ▲ +2.28% | $426.69 (+13.73%) |
Apr 27, 2026 22w ago | 8-K | $431.48 $392.42 | ▼ −9.05% | ▼ −14.52% | $426.69 (−1.11%) |
Apr 27, 2026 22w ago | Court Ruling | $445.70 $392.48 | ▼ −11.94% | ▼ −16.87% | $426.69 (−4.26%) |
Apr 24, 2026 23w ago | 8-K | $432.55 $392.56 | ▼ −9.25% | ▼ −13.27% | $426.69 (−1.36%) |
Mar 13, 2026 29w ago | DEFA14A | $525.04 $496.74 | ▼ −5.39% | ▼ −9.17% | $426.69 (−18.73%) |
Feb 25, 2026 31w ago | 8-K | $525.78 $479.78 | ▼ −8.75% | ▼ −2.35% | $426.69 (−18.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access